Published in Nat Clin Pract Nephrol on April 01, 2007
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler Thromb Vasc Biol (2009) 1.67
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev (2012) 1.31
Application of label-free quantitative peptidomics for the identification of urinary biomarkers of kidney chronic allograft dysfunction. Mol Cell Proteomics (2009) 1.18
Hypertensive crisis in children. Pediatr Nephrol (2011) 1.07
Bradykinin acutely inhibits activity of the epithelial Na+ channel in mammalian aldosterone-sensitive distal nephron. Am J Physiol Renal Physiol (2011) 1.06
Kallikrein transduced mesenchymal stem cells protect against anti-GBM disease and lupus nephritis by ameliorating inflammation and oxidative stress. PLoS One (2013) 0.95
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ Res (2010) 0.94
Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 0.93
Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. Hum Gene Ther (2012) 0.88
Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms. PLoS One (2013) 0.86
Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective. Int J Nephrol Urol (2010) 0.82
Blockade of renal medullary bradykinin B2 receptors increases tubular sodium reabsorption in rats fed a normal-salt diet. Am J Physiol Renal Physiol (2008) 0.81
Kinin-B2 receptor activity determines the differentiation fate of neural stem cells. J Biol Chem (2012) 0.81
From an ACE polymorphism to genome-wide searches for eQTL. J Clin Invest (2013) 0.80
Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus. PLoS One (2014) 0.78
Thyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression. Endocrinology (2011) 0.78
Genome-wide analysis of gestational gene-environment interactions in the developing kidney. Physiol Genomics (2014) 0.78
Ontogeny of bradykinin B1 receptors in the mouse kidney. Pediatr Res (2009) 0.77
A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium. ACS Chem Neurosci (2012) 0.77
Conditional knockout of collecting duct bradykinin B2 receptors exacerbates angiotensin II-induced hypertension during high salt intake. Clin Exp Hypertens (2015) 0.76
Role of human tissue kallikrein in gastrointestinal stromal tumour invasion. Br J Cancer (2010) 0.76
Vascular Kinin B1 and B2 Receptors Determine Endothelial Dysfunction through Neuronal Nitric Oxide Synthase. Front Physiol (2017) 0.75
Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res (2009) 3.25
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation (2011) 1.99
Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res (2010) 1.94
Genetic deletion of the p66Shc adaptor protein protects from angiotensin II-induced myocardial damage. Hypertension (2005) 1.88
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res (2011) 1.78
Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation (2010) 1.69
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler Thromb Vasc Biol (2009) 1.67
Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler Thromb Vasc Biol (2010) 1.63
Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice. Circ Res (2010) 1.63
Cardiovascular actions of neurotrophins. Physiol Rev (2009) 1.45
Diabetes mellitus induces bone marrow microangiopathy. Arterioscler Thromb Vasc Biol (2009) 1.34
Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am J Pathol (2007) 1.31
Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res (2011) 1.30
Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles. Circ Res (2008) 1.29
MicroRNA regulation in angiogenesis. Vascul Pharmacol (2011) 1.27
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs. FASEB J (2004) 1.27
MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res (2012) 1.19
Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail (2010) 1.19
Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells (2012) 1.18
Intravenous gene therapy with PIM-1 via a cardiotropic viral vector halts the progression of diabetic cardiomyopathy through promotion of prosurvival signaling. Circ Res (2011) 1.18
Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions. Arterioscler Thromb Vasc Biol (2007) 1.16
Perivascular delivery of encapsulated mesenchymal stem cells improves postischemic angiogenesis via paracrine activation of VEGF-A. Arterioscler Thromb Vasc Biol (2013) 1.11
Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Circ Res (2010) 1.10
Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies. Cardiovasc Res (2008) 1.10
Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response. J Mol Cell Cardiol (2010) 1.08
Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects. Circulation (2012) 1.07
Protease-activated receptor-2 stimulates angiogenesis and accelerates hemodynamic recovery in a mouse model of hindlimb ischemia. Circ Res (2002) 1.05
Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation). Pharmacol Ther (2010) 1.05
MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med (2011) 1.02
Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes. Cardiovasc Res (2012) 1.00
Nerve growth factor gene therapy using adeno-associated viral vectors prevents cardiomyopathy in type 1 diabetic mice. Diabetes (2012) 1.00
Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium. Regen Med (2006) 0.98
Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells (2014) 0.95
Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ Res (2010) 0.94
Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther (2013) 0.94
Rapid onset of cardiomyopathy in STZ-induced female diabetic mice involves the downregulation of pro-survival Pim-1. Cardiovasc Diabetol (2014) 0.92
Possible novel targets for therapeutic angiogenesis. Curr Opin Pharmacol (2008) 0.91
Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension (2003) 0.91
Neurotrophin-3 is a novel angiogenic factor capable of therapeutic neovascularization in a mouse model of limb ischemia. Arterioscler Thromb Vasc Biol (2010) 0.88
Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway. Arterioscler Thromb Vasc Biol (2013) 0.88
Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation (2002) 0.88
Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises. Vascul Pharmacol (2012) 0.88
Ex vivo molecular rejuvenation improves the therapeutic activity of senescent human cardiac stem cells in a mouse model of myocardial infarction. Stem Cells (2014) 0.87
Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice. Cardiovasc Res (2012) 0.87
Apricot melanoidins prevent oxidative endothelial cell death by counteracting mitochondrial oxidation and membrane depolarization. PLoS One (2012) 0.86
Circulating tissue kallikrein levels correlate with severity of carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 0.84
Diabetes-induced epigenetic signature in vascular cells. Endocr Metab Immune Disord Drug Targets (2012) 0.83
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation (2005) 0.83
Human fetal aorta-derived vascular progenitor cells: identification and potential application in ischemic diseases. Cytotechnology (2008) 0.82
Genetic and dietary control of plasma tissue kallikrein secretion and urinary kinins exretion in man. J Hypertens (2008) 0.82
A journey from basic stem cell discovery to clinical application: the case of adventitial progenitor cells. Regen Med (2015) 0.82
Soluble ST2 is regulated by p75 neurotrophin receptor and predicts mortality in diabetic patients with critical limb ischemia. Arterioscler Thromb Vasc Biol (2012) 0.81
Blood flow and stem cells in vascular disease. Cardiovasc Res (2013) 0.80
The MDM2-p53 pathway: multiple roles in kidney development. Pediatr Nephrol (2014) 0.80
Switching on reparative angiogenesis: essential role of the vascular erythropoietin receptor. Circ Res (2007) 0.79
MicroRNAs in Postischemic Vascular Repair. Cardiol Res Pract (2012) 0.79
Diagnosis of congenital nephrotic syndrome: a clinical and a pathologic challenge. Pediatr Pathol Mol Med (2003) 0.78
Ontogeny of bradykinin B1 receptors in the mouse kidney. Pediatr Res (2009) 0.77
Migratory activity of circulating mononuclear cells is associated with cardiovascular mortality in type 2 diabetic patients with critical limb ischemia. Diabetes Care (2014) 0.77
Genetically engineered stem cell therapy for tissue regeneration. Ann N Y Acad Sci (2004) 0.77
Renin-angiotensin and kallikrein-kinin systems coordinately modulate angiogenesis. Hypertension (2002) 0.77
miRNAs in post-ischaemic angiogenesis and vascular remodelling. Biochem Soc Trans (2014) 0.77
Circulating MicroRNAs as new biomarkers of ischaemia/reperfusion injury during cardiac surgery. Cardiology (2015) 0.77
Oxidative stress-dependent activation of collagen synthesis is induced in human pulmonary smooth muscle cells by sera from patients with scleroderma-associated pulmonary hypertension. Orphanet J Rare Dis (2014) 0.76
S100A1: A novel and essential molecular component for postischemic angiogenesis. Circ Res (2013) 0.75
Emergency management of hypertension in children. Int J Nephrol (2012) 0.75
Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy. Ophthalmologica (2004) 0.75
Diabetes cardiovascular complications. Endocr Metab Immune Disord Drug Targets (2012) 0.75
Diagnostic tools for the study of vascular cognitive dysfunction in hypertension and antihypertensive drug research. Pharmacol Ther (2005) 0.75
MicroRNAs in vascular biology, an introduction to the Vascular Pharmacology special issue on microRNAs. Vascul Pharmacol (2011) 0.75
C1q nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol (2010) 0.75